How do you break into pharmacovigilance?
Through case processing. Individual case safety reports and MedDRA coding are the standard entry point, and clinical or scientific backgrounds transfer well because you already understand medical terminology and rigour. The barrier is rarely capability; it is translation. Your nursing, lab or clinical-research experience has to be written in drug-safety language, pass the ATS, and reach the sponsors, CROs and specialist PV providers that actually hire at entry level.
Pharmacovigilance is one of the most accessible entry points into the pharmaceutical industry for people with a clinical or scientific background, and one of the most resilient functions once you are in. Drug safety does not slow down when hiring elsewhere does; medicines have to be monitored regardless of the market. That makes it a smart target, and a competitive one.
Having recruited scientific and safety talent inside pharma, here is how people actually move into it, and where the transition tends to get stuck.
Why your background probably transfers
If you come from nursing, a laboratory, or clinical research, you already have the two things PV hiring managers care most about at entry level: comfort with medical terminology and a habit of rigour. You understand adverse events instinctively. You know that documentation matters. What you may lack is the vocabulary of the function, and that is fixable.
The entry point: case processing
Almost everyone starts in case processing, handling individual case safety reports (ICSRs) and coding events in MedDRA. It is detailed, high-volume work, and it teaches you the mechanics of safety from the ground up. From there the path opens toward PV Scientist or Officer, then PV Manager, and on to signal management, aggregate reporting, risk management and QPPV-adjacent roles.
The rise of outsourced and remote case processing has genuinely widened the door, with specialist PV service providers hiring at scale. It has also increased the number of applicants per role, which is exactly why precise positioning matters more, not less.
What a pharmacovigilance CV has to show
When drug-safety CVs crossed my desk, the strong ones were exact about scope and systems. For an entry candidate that means signalling the transferable parts clearly: medical knowledge, attention to detail, any exposure to adverse-event reporting or GCP. For someone already in PV it means the specifics: ICSR case processing, MedDRA coding, safety databases such as Oracle Argus or ArisGlobal LifeSphere, signal detection, aggregate reports (PSUR/PBRER, DSUR), risk management plans, literature monitoring, EudraVigilance and the GVP modules, with case volumes and product types named.
For a full breakdown of the function, the employers hiring across DACH, and how the sponsor-versus-CRO-versus-provider choice shapes your career, see the dedicated guide: Pharmacovigilance & drug safety careers in DACH pharma.
The DACH-specific reality
Much case processing and many global roles run in English, but German helps for national and QPPV-facing work and widens your options. The other decision is where you sit: a sponsor, a CRO, or a dedicated PV provider each offers a different rhythm, and a different route to the more sought-after signal and aggregate work. Being deliberate about that early saves you a lateral move later.
A note on salary
I will not invent a PV salary figure. It depends on seniority, employer type, region and whether you have moved beyond case-level work into signal and aggregate reporting, and any number without those caveats would mislead. The bigger lever is progression: the move from case processing to signal and risk-management work changes the range more than a negotiation ever will.
The move that actually works
Breaking into PV, or stepping up within it, rarely happens by applying cold. It works when your clinical or scientific experience is translated into drug-safety language, your CV passes the ATS, and you are put in front of the sponsors, CROs and PV providers that hire, including the roles that never reach the public job boards.
© 13 July 2026 Andreas Schulz. All rights reserved.
Targeting a move into drug safety?
Book a free getting-to-know call. I will tell you honestly whether PV is a realistic target from your background and what the shortest credible path looks like.
Book a Free Getting to Know Call